IL137458A0 - Genetic immunization with nonstructural proteins of hepatitis c virus - Google Patents

Genetic immunization with nonstructural proteins of hepatitis c virus

Info

Publication number
IL137458A0
IL137458A0 IL13745899A IL13745899A IL137458A0 IL 137458 A0 IL137458 A0 IL 137458A0 IL 13745899 A IL13745899 A IL 13745899A IL 13745899 A IL13745899 A IL 13745899A IL 137458 A0 IL137458 A0 IL 137458A0
Authority
IL
Israel
Prior art keywords
hepatitis
virus
nonstructural proteins
genetic immunization
immunization
Prior art date
Application number
IL13745899A
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of IL137458A0 publication Critical patent/IL137458A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL13745899A 1998-01-30 1999-01-28 Genetic immunization with nonstructural proteins of hepatitis c virus IL137458A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7315698P 1998-01-30 1998-01-30
PCT/US1999/001823 WO1999038880A1 (en) 1998-01-30 1999-01-28 Genetic immunization with nonstructural proteins of hepatitis c virus

Publications (1)

Publication Number Publication Date
IL137458A0 true IL137458A0 (en) 2001-07-24

Family

ID=22112053

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13745899A IL137458A0 (en) 1998-01-30 1999-01-28 Genetic immunization with nonstructural proteins of hepatitis c virus

Country Status (9)

Country Link
EP (1) EP1056762A4 (en)
JP (1) JP2002501737A (en)
KR (2) KR100628411B1 (en)
CN (3) CN100335637C (en)
AU (1) AU746258B2 (en)
BR (1) BR9908540A (en)
CA (1) CA2318744A1 (en)
IL (1) IL137458A0 (en)
WO (1) WO1999038880A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030812A2 (en) * 1999-10-27 2001-05-03 Chiron Corporation Activation of hcv-specific t cells
US6986892B1 (en) 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
ATE376558T1 (en) * 1999-11-24 2007-11-15 Novartis Vaccines & Diagnostic NEW NON-STRUCTURAL HCV POLYPEPTIDE
CN1582337B (en) 2001-10-11 2011-12-14 默沙东公司 Hepatitis c virus vaccine
FR2855758B1 (en) 2003-06-05 2005-07-22 Biomerieux Sa COMPOSITION COMPRISING NS3 / NS4 POLYPROTEIN AND HCV NS5B POLYPEPTIDE, EXPRESSION VECTORS INCLUDING THE CORRESPONDING NUCLEIC SEQUENCES AND THEIR USE IN THERAPEUTICS
EP2771035B1 (en) * 2011-10-24 2018-04-11 The Trustees Of The University Of Pennsylvania Improved hcv vaccines and methods for using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2079105C (en) * 1990-04-04 2000-06-13 Michael Houghton Hepatitis c virus protease
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
ATE302854T1 (en) * 1993-01-26 2005-09-15 Univ Pennsylvania COMPOSITIONS AND METHODS FOR ADMINISTRATION OF GENETIC MATERIAL
WO1996037606A1 (en) * 1995-05-22 1996-11-28 Bionova Corporation Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv)
DK0935662T3 (en) * 1996-05-24 2006-03-06 Chiron Corp Fusion protein with multiple epitopes
CA2257137A1 (en) * 1996-06-11 1997-12-18 Merck & Co., Inc. Synthetic hepatitis c genes
WO1999029843A1 (en) * 1997-12-11 1999-06-17 Smithkline Beecham Corporation Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds

Also Published As

Publication number Publication date
KR20060057653A (en) 2006-05-26
CN101126094A (en) 2008-02-20
AU746258B2 (en) 2002-04-18
BR9908540A (en) 2000-11-28
KR20010086226A (en) 2001-09-10
CN101126095A (en) 2008-02-20
CN100335637C (en) 2007-09-05
CA2318744A1 (en) 1999-08-05
WO1999038880A1 (en) 1999-08-05
CN1289339A (en) 2001-03-28
AU2478699A (en) 1999-08-16
JP2002501737A (en) 2002-01-22
EP1056762A4 (en) 2003-07-23
KR100628411B1 (en) 2006-09-28
EP1056762A1 (en) 2000-12-06

Similar Documents

Publication Publication Date Title
PL324906A1 (en) Vaccines against viral hepatitis of c type
IL131688A0 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
DE60014345D1 (en) Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore
PL321966A1 (en) Vaccine against viral hepatitis of b type
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
DK1001801T3 (en) Product comprising at least one double-chain RNA combined with at least one interferon for the treatment of viral hepatitis
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
ZA9811316B (en) Novel hepatitis C virus NS5B protein
EP1627917A4 (en) NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO
ZA985762B (en) Screening methods using an atpase protein from a virus of the flaviviridae family
AU7602800A (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
HK1062579A1 (en) A fusion protein for treatment of hepatitis b virus and its use thereof
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
IL137458A0 (en) Genetic immunization with nonstructural proteins of hepatitis c virus
EP1100545A4 (en) Regulated expression of recombinant proteins using rna viruses
IL138804A0 (en) Hepatitis c virus ns5b nucleic acids and proteins
EP1113777A4 (en) Novel hepatitis c virus peptides and uses thereof
AU9494998A (en) (in vivo), animal model for expression of hepatitis c virus
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
EP1521849A4 (en) Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
AU5681598A (en) Liposomes comprising peptide antigens derived from x protein of hepatitis b virus